An interleukin-1 alpha (IL-1 alpha ) derivative having a modified amino acid sequence of IL-1 alpha , a gene coding for said derivative, medicinal composition comprising said derivative as a pharmaceutically effective component and a medicinal use of homogeneous IL-1 alpha .